Condition: Solid Tumors · Sponsor: DualityBio Inc.
A Phase II, Multicenter, Open-Label Trial of DB-1311 in combination with BNT327 or DB-1305 in Participants with Advanced/Metastatic Solid Tumors
This description comes directly from the study's public registry record.
Jay Ma · 540-808-3925 · jay.ma@dualitybiologics.com
Qiaoli Jiang · +86-15210642683 · qiaoli.jiang@dualitybiologics.com
Always discuss trial participation with your own doctor first.
| USA06-0 | Los Angeles, California, United States | Recruiting |
| USA16-0 | Los Angeles, California, United States | Recruiting |
| USA01-0 | Wheat Ridge, Colorado, United States | Recruiting |
| USA08-0 | Florida City, Florida, United States | Recruiting |
| USA10-0 | Atlanta, Georgia, United States | Recruiting |
| USA11-0 | Bethesda, Maryland, United States | Recruiting |
| USA14-0 | Lincoln, Nebraska, United States | Recruiting |
| USA04-0 | New York, New York, United States | Recruiting |
| USA15-0 | Portland, Oregon, United States | Recruiting |
| USA03-0 | Charleston, South Carolina, United States | Recruiting |
| USA13-0 | Anderson, Texas, United States | Recruiting |
| USA12-0 | Houston, Texas, United States | Recruiting |
+ 25 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06953089